Sponsored by:
Tech Transfer Strategies and Best Practices to Optimize Your Clinical and Commercial Supply
Tech transfers for biological products, whether they occur from a pharma company, another CMO, or a different site within the same organization, are complex and challenging processes. This insightful webinar explores the critical aspects of technology transfer of either drug substance or drug product.
Explore innovative solutions to:
- Accelerate clinical tech transfer for drug products, enabling a released clinical batch within five months from kick-off
- Seamless process transfer for at-scale 2kL GMP manufacturing with parallel process development for enhanced cell culture titer and reduced material cost
Additionally, Lonza experts focus on the unique challenges of biologics manufacturing, discussing the intricacies of transferring complex biologic drug substances from development to large-scale production. Learn about the specific considerations for maintaining the stability, efficacy, and safety of biologics throughout the tech transfer process.
